4.5 Review

Expression of LINC00174 in different cancers: Review of the literature and bioinformatics analyses

Related references

Note: Only part of the references are listed.
Review Pathology

A review on the role of GHET1 in different cancers

Soudeh Ghafouri-Fard et al.

Summary: This review summarizes recent studies on the expression of GHET1, its in vitro functions, and its impact on the beginning and progression of cancer based on xenograft models, highlighting the correlation between up-regulation of GHET1 and poor prognosis in various malignancies.

PATHOLOGY RESEARCH AND PRACTICE (2023)

Article Biochemistry & Molecular Biology

RNAInter v4.0: RNA interactome repository with redefined confidence scoring system and improved accessibility

Juanjuan Kang et al.

Summary: The study updated the RNAInter database to version 4.0, which includes an enlarged data set and an updated confidence scoring system, providing a faster and more user-friendly interface, with over 47 million total entries. This will offer a more comprehensive and readily accessible RNA interactome platform for investigating the regulatory landscape of cellular RNAs.

NUCLEIC ACIDS RESEARCH (2022)

Article Genetics & Heredity

Downregulated long intergenic non-coding RNA 00,174 represses malignant biological behaviors of lung cancer cells by regulating microRNA-584-3p/ribosomal protein S24 axis

Shaobin Wang et al.

Summary: This study reveals the impact of LINC00174 on the malignant phenotype in lung cancer cells through modulating the miR-584-3p/RPS24 axis.

FUNCTIONAL & INTEGRATIVE GENOMICS (2022)

Article Immunology

LINC00174 promotes cell proliferation and metastasis in renal clear cell carcinoma by regulating miR-612/FOXM1 axis

Xiaoshan Li et al.

Summary: LINC00174 is highly expressed in KIRC and is associated with up-regulation of FOXM1 expression and down-regulation of miR-612 expression. LINC00174 promotes the proliferation and metastatic potential of KIRC cells by regulating the miR-612/FOXM1 axis.

IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2022)

Article Biotechnology & Applied Microbiology

Long Intergenic Nonprotein Coding RNA 00174 Aggravates Lung Squamous Cell Carcinoma Progression via MicroRNA-185-5p/Nuclear Factor IX axis

Peipei Gu et al.

Summary: This study reveals that LINC00174 is highly expressed in lung squamous cell carcinoma (LUSC) and plays a role in regulating the biological processes of LUSC. It interacts with miR-185-5p to upregulate the expression of NFIX, thereby promoting the progression of LUSC.

BIOMED RESEARCH INTERNATIONAL (2022)

Article Oncology

Expression pattern of non-coding RNAs in non-functioning pituitary adenoma

Soudeh Ghafouri-Fard et al.

Summary: This study identified differentially expressed genes (DEGs), including long non-coding RNAs (DElncRNAs) and microRNAs (DEmiRNAs), in non-functioning pituitary adenomas (NFPA) compared to normal samples. The study also assessed the relationship between these genes and important signaling pathways. The findings revealed dysregulated pathways and differential expression of several genes in NFPA.

FRONTIERS IN ONCOLOGY (2022)

Article Clinical Neurology

Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA

Aierpati Maimaiti et al.

Summary: This study identified nine immune-related lncRNAs with prognostic value for low-grade glioma, which could serve as prognostic markers and potentially guide management strategies. These lncRNAs were found to influence tumorigenesis and prognosis in low-grade glioma by modulating immune responses and cancer pathways.

CLINICAL NEUROLOGY AND NEUROSURGERY (2021)

Article Oncology

A Novel Prognostic Prediction Model for Colorectal Cancer Based on Nine Autophagy-Related Long Noncoding RNAs

Guoqiang Xu et al.

Summary: This study established a prognostic prediction model of CRC based on nine ARlncRNAs, which accurately predicted the 1-year overall survival rate and identified the model risk score as an independent predictor of CRC. LINC00174 and NKILA were found to be expressed in both the nucleus and cytoplasm of normal colonic epithelial cells and colorectal cancer cells, with overexpression in cancer cells.

FRONTIERS IN ONCOLOGY (2021)

Article Biotechnology & Applied Microbiology

LINC00174 Facilitates Proliferation and Migration of Colorectal Cancer Cells via MiR-3127-5p/E2F7 Axis

Yuhong Ma et al.

Summary: The study reveals that LINC00174 affects the biological characteristics of CRC cells by regulating the miR-3127-5p/E2F7 axis, promoting cell proliferation and migration. The high expression of LINC00174 enhances CRC cell viability, proliferation, migration, and invasion by up-regulating N-Cadherin, Vimentin, E2F7, and inhibiting ECadherin expression.

JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2021)

Article Biochemistry & Molecular Biology

LINC00174 is an oncogenic lncRNA of hepatocellular carcinoma and regulates miR-320/S100A10 axis

Jin-Tao Zhao et al.

CELL BIOCHEMISTRY AND FUNCTION (2020)

Review Medicine, Research & Experimental

MicroRNAs as regulators of ERK/MAPK pathway: A comprehensive review

Amin Safa et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Review Oncology

The Role of Non-Coding RNAs in Controlling Cell Cycle Related Proteins in Cancer Cells

Soudeh Ghafouri-Fard et al.

FRONTIERS IN ONCOLOGY (2020)

Review Medicine, General & Internal

Long Non-coding RNAs in Cancer: Implications for Diagnosis, Prognosis, and Therapy

Yuchen Qian et al.

FRONTIERS IN MEDICINE (2020)

Article Oncology

Long non-coding RNA LINC00174 promotes glycolysis and tumor progression by regulating miR-152-3p/SLC2A1 axis in glioma

Jian Shi et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Article Medicine, Research & Experimental

Role of linc00174/miR-138-5p (miR-150-5p)/FOSL2 Feedback Loop on Regulating the Blood-Tumor Barrier Permeability

Jizhe Guo et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2019)

Review Genetics & Heredity

Long noncoding RNA (lincRNA), a new paradigm in gene expression control

Emre Deniz et al.

FUNCTIONAL & INTEGRATIVE GENOMICS (2017)